Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 5 Sponsors

Feb 19, 2026 · House

Stricken from Calendar by Rule 1507

Feb 18, 2026 · House

Committee of the Whole - Passed over and retain a place on the calendar

Jan 28, 2026 · House

Committee Report recommending bill be passed as amended by House Committee on Health and Human Services

Feb 3, 2025 · House

Referred to House Committee on Health and Human Services

Feb 3, 2025 · House

Introduced

PASSAGE PROBABILITY

1.5% Unlikely

Why this number

Stage base Reported from Committee — base rate 26%, measured from KS's completed sessions
Momentum -2 40/100 from the pace of recorded action
Time since last action -22 614 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.